Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents : Synthesis and Biological Evaluation
© 2022 Published by Elsevier B.V..
During the ongoing pandemic, there have been increasing reports of invasive fungal disease (IFD), particularly among immunocompromised populations. Candida albicans is one of the most common clinical pathogenic microorganisms which have become a serious health threat to population either infected with Covid-19 or on treatment with immunosuppressant's/broad-range antibiotics. Currently, benzothiazole is a well explored scaffold for anti-fungal activity, especially mercapto substituted benzothiazoles. It is reported that exploring the 2nd position of benzothiazoles yield improved anti-fungal molecules. Therefore, in the current study, lead optimization approach using bioisosteric replacement protocol was followed to improve the anti-fungal activity of an already reported benzothiazole derivative, N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide. To rationally identify the putative anti-candida targets of this derivative, network analysis was carried out. Complexes of designed compounds and identified putative targets were further analyzed for the docking interactions and their consequent retention after the completion of exhaustive MD simulations. Top seven designed compounds were synthesized and evaluated for in-vitro anti-fungal property against Candida, which indicated that compounds 1.2c and 1.2f possess improved and comparable anti-fungal activity to N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide and Nystatin, respectively.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2022 |
|---|---|
| Enthalten in: |
Journal of molecular structure - (2022) vom: 09. Sept., Seite 134128 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Manmeet [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2-aminobenzothiazole |
|---|
| Anmerkungen: |
Date Revised 16.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.molstruc.2022.134128 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346187060 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346187060 | ||
| 003 | DE-627 | ||
| 005 | 20240217232048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molstruc.2022.134128 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1297.xml |
| 035 | |a (DE-627)NLM346187060 | ||
| 035 | |a (NLM)36101882 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Singh, Manmeet |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents |b Synthesis and Biological Evaluation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © 2022 Published by Elsevier B.V. | ||
| 520 | |a During the ongoing pandemic, there have been increasing reports of invasive fungal disease (IFD), particularly among immunocompromised populations. Candida albicans is one of the most common clinical pathogenic microorganisms which have become a serious health threat to population either infected with Covid-19 or on treatment with immunosuppressant's/broad-range antibiotics. Currently, benzothiazole is a well explored scaffold for anti-fungal activity, especially mercapto substituted benzothiazoles. It is reported that exploring the 2nd position of benzothiazoles yield improved anti-fungal molecules. Therefore, in the current study, lead optimization approach using bioisosteric replacement protocol was followed to improve the anti-fungal activity of an already reported benzothiazole derivative, N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide. To rationally identify the putative anti-candida targets of this derivative, network analysis was carried out. Complexes of designed compounds and identified putative targets were further analyzed for the docking interactions and their consequent retention after the completion of exhaustive MD simulations. Top seven designed compounds were synthesized and evaluated for in-vitro anti-fungal property against Candida, which indicated that compounds 1.2c and 1.2f possess improved and comparable anti-fungal activity to N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide and Nystatin, respectively | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 2-aminobenzothiazole | |
| 650 | 4 | |a Molecular docking | |
| 650 | 4 | |a Molecular dynamics | |
| 650 | 4 | |a Network analysis | |
| 700 | 1 | |a Verma, Himanshu |e verfasserin |4 aut | |
| 700 | 1 | |a Bhandu, Priyanka |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Manoj |e verfasserin |4 aut | |
| 700 | 1 | |a Narendra, Gera |e verfasserin |4 aut | |
| 700 | 1 | |a Choudhary, Shalki |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Pankaj Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Silakari, Om |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of molecular structure |d 1986 |g (2022) vom: 09. Sept., Seite 134128 |w (DE-627)NLM114359369 |x 0022-2860 |7 nnns |
| 773 | 1 | 8 | |g year:2022 |g day:09 |g month:09 |g pages:134128 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.molstruc.2022.134128 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 09 |c 09 |h 134128 | ||